Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Int Rev Psychiatry ; 34(6): 622-631, 2022 09.
Article in English | MEDLINE | ID: mdl-36695202

ABSTRACT

Family reunification occurs when migrants relocate without intact family units, and later reunite in new countries. Family serial migration and reunification is a global issue, relating to both voluntary and involuntary migrants who seek physical safety, psychological well-being, and economic self-sufficiency in new countries. Early studies alluded to a joyful family reconsolidation, while recent studies have found stressful reunions. This study provides an overview of the family reunification process of Latinx adolescents who have migrated to join their families in the United States (U.S.). The study conducted detailed interviews of 20 Latinx adolescents, aged 12-18 years old, in order to provide an in-depth examination of their pre and postmigration experiences. The results reveal three phases of family reunification: Latinx adolescents' experiences after their parent(s) left to migrate to the U.S.; their own migration journey to the U.S.; and their family reunification, adaptation, and adjustment to the U.S. The findings suggest that it is essential for mental health professionals to understand and acknowledge the multiple psychosocial challenges of Latinx adolescents' reuniting with their families in a new country. This includes feelings of abandonment and grief after their parent(s) departure to the U.S., their own migration journey to the U.S. which may have been experienced as traumatic, and psychosocial challenges in adjustment and adaptation in the U.S. after family reunification.


Subject(s)
Emigrants and Immigrants , Transients and Migrants , Adolescent , Humans , United States , Child , Family/psychology , Hispanic or Latino
2.
Pesqui. vet. bras ; 32(5): 419-423, maio 2012. graf, tab
Article in English | LILACS | ID: lil-626482

ABSTRACT

The aim was to evaluate for 75 days the impact on production of the remaining burden of ivermectin (IVM)-resistant parasites in naturally infected feedlot calves. The herds came from tick-infested areas of cattle breeding where the systematic use of IVM to control tick increases the gastrointestinal parasites resistant to this drug. This investigation was carried out in two commercial feedlots in Buenos Aires province. In feedlot A, two groups of 35 animal each received IVM 1% and the other received ricobendazole (RBZ) 10% respectively. The same was done in feedlot B. On day 0, two groups of 35 animals were made in feedlots A and B. Fecal samples were taken on days 0, 22, 54 and 75 pos-treatment (PT), and body weight was registered, from each animal. Fecal samples were processed for individual count of eggs per gram (EPG) and pooled fecal culture was carried out for identification of the parasite genus in each sampling. Fecal egg count reduction test (FECR) was calculated on day 22 PT. The study design used was a totally randomized block, with commercial feedlot and sex as block variables. For data analysis, a mixed model of the SAS statistical program was used. The FECR average on day 22 was 28.4% in the IVM group, and 94,2 % in the RBZ group . From this date on, significant differences in EPG were kept until day 54. EPG counts were only equal near the end of the trial, on day 75 (p=0.16). In both commercial feedlots, especially in the IVM group, Cooperia spp. was the most prevalent parasite in the fecal cultures. Significant differences in weight (P<0.01) on post-treatment day 75 was found between the average weight in the RBZ and the IVM group (246 vs. 238 kg respectively), what means a difference of 8.3% in gains. The importance for production in the antiparasite failure treatment in commercial feedlots was demonstrated, and the need of pos-treatment controls to evaluate the efficacy of the antiparasitic administered is emphasized.


O objetivo deste trabalho foi avaliar durante 75 dias o impacto sobre a produção da carga de parasita-ivermectina (IVM) resistentes remanescentes em bezerros naturalmente infectados no confinamento. Os rebanhos são provenientes de áreas infestadas por carrapatos, onde o uso sistemático de IVM para o controle do carrapato aumenta a resistência de parasita gastrintestinais a esta droga. Este trabalho foi realizado em dois confinamentos comerciais na província de Buenos Aires. Na fazenda A, dois grupos de 35 animais cada receberam IVM 1% e ricobendazole (RBZ) 10%, respectivamente. O mesmo foi feito no confinamento B. No dia 0, dois grupos de 35 animais foram feitos nas fazendas A e B. As amostras fecais foram tomadas nos dias 0, 22, 54 e 75 pós-tratamento (PT) e o peso corporal foi registrado, de cada animal. Amostras fecais foram processadas para a contagem individual de ovos por grama (EPG). Amostras fecais foram agrupadas para a identificação do gênero parasitária. O teste de redução de ovos fecais (TROF) foi calculado no dia 22 PT. O desenho do estudo utilizado foi aquele dos blocos inteiramente randomizados, sendo confinamento comercial e sexo as variáveis de bloco. Para a análise dos dados, um modelo misto do programa estatístico SAS foi utilizado. A média TROF no dia 22 foi de 28,4% no grupo IVM e 94,2% no grupo RBZ. A partir desta data, diferenças significativas na EPG foram mantidas até o dia 54. Contas de OPG só foram iguais perto do fim do estudo, no dia 75 (p=0,16). Em ambos os confinamentos comerciais, especialmente no grupo IVM, Cooperia spp. foram os parasitos mais prevalentes nas culturas fecais. Diferenças significativas no peso (P<0,01) 75 dias pós-tratamento foram encontradas entre o peso médio nos grupos RBZ e IVM (246 vs 238 kg, respectivamente), o que significa uma diferença de 8,3% nos ganhos. A importância para a produção no tratamento da insuficiência antiparasitários em confinamento comercial foi demonstrada, bem como a necessidade de controles pós-tratamento para avaliar a eficácia dos antiparasitários administrados é enfatizada.


Subject(s)
Animals , Cattle , Cattle/growth & development , Parasitic Diseases, Animal/therapy , Tick Infestations/prevention & control , Ivermectin/administration & dosage , Ivermectin/adverse effects , Antiparasitic Agents/chemistry , Parasitic Diseases, Animal/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL